Jack Hoppin

Jack Hoppin

Company: Ratio Therapeutics

Job title: Chief Executive Officer


Advancing Dosimetry Data: An Invaluable Tool to Optimize Therapeutic Outcomes 11:00 am

Dosimetry data gives precise insight into radiation dose delivery and tissue penetration, but there is still work to be done to unlock the true potential of this tool. From understanding dose-response relationships and establishing safe dose limits for normal organs to overcoming logistical hurdles in clinical implementation. There is ongoing research and development efforts to…Read more

day: Workshop E

Evaluating Novel Radiopharmaceutical Targeting Agents for Enhanced Specificity & Efficacy 8:30 am

As we see more innovation to improve targeting approaches across radio conjugates, the design and development of these molecules is no easy ride. With the aim to balance the specificity, efficacy and radiation exposure to non-targeted tissues, this workshop will critically analyze current targeting approaches. Hear the latest content and dive into discussions on: Uncovering…Read more

day: Workshop A

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.